Media Summary: Ioannis Kostopoulos, MSc, PhD, National and Kapodistrian University of Athens, Athens, Greece discusses the current state of ... Dr. Allan, a Lawson scientist in the London Regional Cancer Program, is a national leader in the study of Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the potential of
Circulating Tumor Cells In Multiple - Detailed Analysis & Overview
Ioannis Kostopoulos, MSc, PhD, National and Kapodistrian University of Athens, Athens, Greece discusses the current state of ... Dr. Allan, a Lawson scientist in the London Regional Cancer Program, is a national leader in the study of Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the potential of Luca Bertamini, MD, Erasmus MC, Rotterdam, Netherlands, discusses a pooled European analysis of 2446 newly diagnosed ... "In 2012, 13.7 million people had a history of During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the
Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, discusses the value of using Susanne Osanto, MD, PhD, from the Leiden University Medical Center, Leiden, Netherlands, discusses the clinical utility of ... Professor Caroline Dive leads the Clinical and Experimental Pharmacology Group at the Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, highlights the potential of assessing If I have early or late-stage disease should I get a test for Massimo Cristofanilli, MD, FACP, Weill Cornell Medicine, New York, NY, explains recent research into
